Cargando…
Biomarkers Assessing Endothelial Dysfunction in Alzheimer’s Disease
Alzheimer’s disease (AD) is the most common degenerative disorder in the elderly in developed countries. Currently, growing evidence is pointing at endothelial dysfunction as a key player in the cognitive decline course of AD. As a main component of the blood–brain barrier (BBB), the dysfunction of...
Autores principales: | Custodia, Antía, Aramburu-Núñez, Marta, Rodríguez-Arrizabalaga, Mariña, Pías-Peleteiro, Juan Manuel, Vázquez-Vázquez, Laura, Camino-Castiñeiras, Javier, Aldrey, José Manuel, Castillo, José, Ouro, Alberto, Sobrino, Tomás, Romaus-Sanjurjo, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047803/ https://www.ncbi.nlm.nih.gov/pubmed/36980302 http://dx.doi.org/10.3390/cells12060962 |
Ejemplares similares
-
Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer’s Disease and Other Neurodegenerative Diseases
por: Custodia, Antía, et al.
Publicado: (2022) -
Endothelial Progenitor Cells and Vascular Alterations in Alzheimer’s Disease
por: Custodia, Antía, et al.
Publicado: (2022) -
Unraveling the potential of endothelial progenitor cells as a treatment following ischemic stroke
por: Custodia, Antía, et al.
Publicado: (2022) -
CD34(+) progenitor cells as diagnostic and therapeutic targets in Alzheimer’s disease
por: Romaus-Sanjurjo, Daniel, et al.
Publicado: (2022) -
Periodontal inflammation is associated with increased circulating levels of endothelial progenitor cells: a retrospective cohort study in a high vascular risk population
por: Vázquez-Reza, María, et al.
Publicado: (2023)